Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sushanta Halder"'
Autor:
Minal Y Nadar, Sushanta Halder, Lokpati Mishra, Deepak K Akar, Indrasen S Singh, Pramilla D Sawant
Publikováno v:
Radiation Protection and Environment, Vol 46, Iss 1, Pp 14-18 (2023)
In routine monitoring of radiation workers to detect internal contamination due to Pu/Am, it is assumed that intake has occurred at the midpoint of the monitoring interval. Radiation worker is normally monitored at the end of the annual monitoring in
Externí odkaz:
https://doaj.org/article/1831c3f3229a4a919ef8dbe694fa9ae5
Autor:
Parthasarathy Seshacharyulu, Sushanta Halder, Ramakrishna Nimmakayala, Satyanarayana Rachagani, Sanjib Chaudhary, Pranita Atri, Ramakanth Chirravuri-Venkata, Michel M. Ouellette, Joseph Carmicheal, Shailendra K. Gautam, Raghupathy Vengoji, Shuo Wang, Sicong Li, Lynette Smith, Geoffrey A. Talmon, Kelsey Klute, Quan Ly, Bradley N Reames, Jean L Grem, Lyudmyla Berim, James C Padussis, Sukhwinder Kaur, Sushil Kumar, Moorthy P. Ponnusamy, Maneesh Jain, Chi Lin, Surinder K Batra
Publikováno v:
EBioMedicine, Vol 75, Iss , Pp 103772- (2022)
Summary: Background: Radiation therapy (RT) has a suboptimal effect in patients with pancreatic ductal adenocarcinoma (PDAC) due to intrinsic and acquired radioresistance (RR). Comprehensive bioinformatics and microarray analysis revealed that choles
Externí odkaz:
https://doaj.org/article/391f86e6510b4029a18fb205640acaf2
Autor:
Sushanta Halder, Soumi Basu, Shobhit Lall, Apar K. Ganti, Surinder K. Batra, Parthasarathy Seshacharyulu
Publikováno v:
Expert Opinion on Therapeutic Targets.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e729b866a371499906beea0f2488dc2
https://doi.org/10.1080/14728222.2023.2218613
https://doi.org/10.1080/14728222.2023.2218613
Autor:
Chunmeng Zhang, Pranita Atri, Palanisamy Nallasamy, Seema Parte, Sanchita Rauth, Rama Krishna Nimmakayala, Saravanakumar Marimuthu, Ramakanth Chirravuri-Venkata, Rakesh Bhatia, Sushanta Halder, Ashu Shah, Jesse L. Cox, Lynette Smith, Sushil Kumar, Jason M. Foster, Rakesh C. Kukreja, Parthasarathy Seshacharyulu, Moorthy P. Ponnusamy, Surinder K. Batra
Publikováno v:
Cancer letters. 551
Mucin MUC4 is an aberrantly expressed oncogene in pancreatic ductal adenocarcinoma (PDAC), yet no pharmacological inhibitors have been identified to target MUC4. Here, we adapted an in silico screening method using the Cancer Therapeutic Response Dat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d62dda2508cf7eb8d11c85a3263ecff
https://pubmed.ncbi.nlm.nih.gov/36285687
https://pubmed.ncbi.nlm.nih.gov/36285687
Autor:
Sushanta Halder, Sakthivel Muniyan, Ramakanth Chirravuri-Venkata, Rama Krishna Nimmakayala, Palanisamy Nallasamy, Hareesh B. Nair, Moorthy P Ponnusamy, Surinder K. Batra, Parthasarathy Seshacharyulu
Publikováno v:
Cancer Research. 83:1756-1756
Background: Docetaxel has been the most effective chemotherapeutic option after the emergence of Castration-resistant prostate cancer (CRPC). However, more than 50% of patients develop Docetaxel Resistance (DoceR) within three years of treatment. It
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12134bb1d6d2b1ec8aba8bc1bc2eb028
https://doi.org/10.1158/1538-7445.am2023-1756
https://doi.org/10.1158/1538-7445.am2023-1756
Publikováno v:
Dhaka University Journal of Pharmaceutical Sciences. 17:251-255
The objective of the study was to evaluate the antinociceptive and anthelmintic activities of the crude methanol extract of leaves of Leea aequata and its fractions. The crude extract and its fractions at 200- and 400-mg/kg bw were subjected to assay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::020bb42032b76312aea93c491f99e319
https://doi.org/10.3329/dujps.v17i2.39183
https://doi.org/10.3329/dujps.v17i2.39183
Autor:
Lei Xi, Prakash Kshirsagar, Anindita Das, Kavita Mallya, Ridwan Islam, Parthasarathy Seshacharyulu, Benjamin A. Teply, Sakthivel Muniyan, Seema Parte, Sushanta Halder, Jawed A. Siddiqui, Sanchita Rauth, Surinder K. Batra, Satyanarayana Rachagani, Kaustubh Datta, Raghupathy Vengoji, Rakesh C. Kukreja
Publikováno v:
Clin Cancer Res
Purpose: Docetaxel plays an indispensable role in the management of advanced prostate cancer. However, more than half of patients do not respond to docetaxel, and those good responders frequently experience significant cumulative toxicity, which limi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::836eab5c54465d2d038f3458af5cdde4
https://pubmed.ncbi.nlm.nih.gov/32847934
https://pubmed.ncbi.nlm.nih.gov/32847934